# Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene

> **NCT06817694** · NA · RECRUITING · sponsor: **CHU de Quebec-Universite Laval** · enrollment: 250 (estimated)

## Conditions studied

- Breast Cancer Susceptibility Gene (BRCA1) Mutation
- BRCA2 Mutation
- Fear of Cancer Recurrence

## Interventions

- **BEHAVIORAL:** Cognitive-behavioral group therapy

## Key facts

- **NCT ID:** NCT06817694
- **Lead sponsor:** CHU de Quebec-Universite Laval
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2026-12
- **Final completion:** 2028-12
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06817694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06817694, "Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06817694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*